22.10.2021 • NewsAir Liquide

Air Liquide Advances French Green Hydrogen Project

Air Liquide has raised its stake in H2V Normandy from 40% to 100%, renaming it Air Liquide Normand’Hy. The French industrial gases group, which bought its original stake only in January, said the strategic investment will support the development of a low-carbon hydrogen ecosystem in the Normandy industrial basin. Financial details of the transaction were not disclosed.

François Jackow, executive vice president and a member of Air Liquide’s executive committee supervising Europe industries activities, commented: “This acquisition is a key milestone in producing renewable hydrogen on a large scale to supply industry and mobility markets. By 2030, Air Liquide is committed to bringing its total electrolysis capacity to 3 gigawatts.”

Air Liquide Normand’Hy plans to build a large-scale electrolyzer of at least 200 MW in the industrial zone of Port Jerome to produce renewable hydrogen. It will be connected to Air Liquide’s hydrogen pipeline network in Normandy.

The proton-exchange membrane (PEM) electrolzyer is expected to be commissioned in 2025, supplying 28,000 t/y of the gas for industrial and heavy mobility applications and avoiding the emission of more than 250,000 t/y of CO2.

In February, the Paris-based firm announced it had agreed to partner Siemens Energy to combine their expertise in PEM electrolysis technology.

Author: Elaine Burridge, Freelance Journalist

Air Liquide has raised its stake in H2V Normandy from 40% to 100%, renaming it...
Air Liquide has raised its stake in H2V Normandy from 40% to 100%, renaming it Air Liquide Normand’Hy. The company plans to build a large-scale electrolyzer of at least 200 megawatts in Port Jerome to produce 28,000 t/y renewable hydrogen with startup expected in 2025. (c) Air Liquide

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.

Free Virtual Event

ProteiNext 2025

ProteiNext 2025

ProteiNext is an annual symposium that offers a platform for sharing insights on protein analysis